Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

337 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Management of patients with multidrug-resistant tuberculosis.
Lange C, Aarnoutse RE, Alffenaar JWC, Bothamley G, Brinkmann F, Costa J, Chesov D, van Crevel R, Dedicoat M, Dominguez J, Duarte R, Grobbel HP, Günther G, Guglielmetti L, Heyckendorf J, Kay AW, Kirakosyan O, Kirk O, Koczulla RA, Kudriashov GG, Kuksa L, van Leth F, Magis-Escurra C, Mandalakas AM, Molina-Moya B, Peloquin CA, Reimann M, Rumetshofer R, Schaaf HS, Schön T, Tiberi S, Valda J, Yablonskii PK, Dheda K. Lange C, et al. Among authors: kirk o. Int J Tuberc Lung Dis. 2019 Jun 1;23(6):645-662. doi: 10.5588/ijtld.18.0622. Int J Tuberc Lung Dis. 2019. PMID: 31315696 Review.
A new health care index predicts short term mortality for TB and HIV co-infected people.
Roen AO, Podlekareva D, Miller RF, Mocroft A, Panteleev A, Skrahina A, Miro JM, Cayla JA, Tetradov S, Derisova E, Furrer H, Losso MH, Vassilenko A, Girardi E, Lundgren JD, Post FA, Kirk O. Roen AO, et al. Among authors: kirk o. Int J Tuberc Lung Dis. 2020 Sep 1;24(9):956-962. doi: 10.5588/ijtld.19.0568. Int J Tuberc Lung Dis. 2020. PMID: 33156764
Health care index score and risk of death following tuberculosis diagnosis in HIV-positive patients.
Podlekareva DN, Grint D, Post FA, Mocroft A, Panteleev AM, Miller RF, Miro JM, Bruyand M, Furrer H, Riekstina V, Girardi E, Losso MH, Caylá JA, Malashenkov EA, Obel N, Skrahina AM, Lundgren JD, Kirk O; HIV-TB Study Group. Podlekareva DN, et al. Among authors: kirk o. Int J Tuberc Lung Dis. 2013 Feb;17(2):198-206. doi: 10.5588/ijtld.12.0224. Int J Tuberc Lung Dis. 2013. PMID: 23317955 Free article.
Management of MDR-TB in HIV co-infected patients in Eastern Europe: Results from the TB:HIV study.
Efsen AMW, Schultze A, Miller RF, Panteleev A, Skrahin A, Podlekareva DN, Miro JM, Girardi E, Furrer H, Losso MH, Toibaro J, Caylà JA, Mocroft A, Lundgren JD, Post FA, Kirk O; TB: HIV study in EuroCoord. Efsen AMW, et al. Among authors: kirk o. J Infect. 2018 Jan;76(1):44-54. doi: 10.1016/j.jinf.2017.10.007. Epub 2017 Oct 20. J Infect. 2018. PMID: 29061336 Free PMC article.
Healthcare delivery for HIV-positive people with tuberculosis in Europe.
Bentzon AK, Panteleev A, Mitsura V, Borodulina E, Skrahina A, Denisova E, Tetradov S, Podlasin R, Riekstina V, Kancauskiene Z, Paduto D, Mocroft A, Trofimova T, Miller R, Post F, Grezesczuk A, Lundgren JD, Inglot M, Podlekareva D, Bolokadze N, Kirk O; TB:HIV Study Group. Bentzon AK, et al. Among authors: kirk o. HIV Med. 2021 Apr;22(4):283-293. doi: 10.1111/hiv.13016. Epub 2020 Nov 20. HIV Med. 2021. PMID: 33215809 Free PMC article.
Uptake of the lateral flow urine LAM test in Europe and Central Asia.
Kraef C, Yedilbayev A, Seguy N, Bentzon A, Podlekareva D, Cirillo DM, van der Werf MJ, Kirk O. Kraef C, et al. Among authors: kirk o. Int J Tuberc Lung Dis. 2022 Sep 1;26(9):835-841. doi: 10.5588/ijtld.21.0656. Int J Tuberc Lung Dis. 2022. PMID: 35996279 Free PMC article.
Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?
Fontas E, van Leth F, Sabin CA, Friis-Møller N, Rickenbach M, d'Arminio Monforte A, Kirk O, Dupon M, Morfeldt L, Mateu S, Petoumenos K, El-Sadr W, de Wit S, Lundgren JD, Pradier C, Reiss P; D:A:D Study Group. Fontas E, et al. Among authors: kirk o. J Infect Dis. 2004 Mar 15;189(6):1056-74. doi: 10.1086/381783. Epub 2004 Mar 2. J Infect Dis. 2004. PMID: 14999610
TB meningitis in HIV-positive patients in Europe and Argentina: clinical outcome and factors associated with mortality.
Efsen AM, Panteleev AM, Grint D, Podlekareva DN, Vassilenko A, Rakhmanova A, Zeltina I, Losso MH, Miller RF, Girardi E, Caylá J, Post FA, Miro JM, Bruyand M, Furrer H, Obel N, Lundgren JD, Mocroft A, Kirk O; HIV/TB Study Group. Efsen AM, et al. Among authors: kirk o. Biomed Res Int. 2013;2013:373601. doi: 10.1155/2013/373601. Epub 2013 Dec 31. Biomed Res Int. 2013. PMID: 24699884 Free PMC article.
Low body weight and type of protease inhibitor predict discontinuation and treatment-limiting adverse drug reactions among HIV-infected patients starting a protease inhibitor regimen: consistent results from a randomized trial and an observational cohort.
Kirk O, Gerstoft J, Pedersen C, Nielsen H, Obel N, Katzenstein TL, Mathiesen L, Lundgren JD. Kirk O, et al. HIV Med. 2001 Jan;2(1):43-51. doi: 10.1046/j.1468-1293.2001.00045.x. HIV Med. 2001. PMID: 11737375 Free article. Clinical Trial.
337 results